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arly steps in myelination in the central nervous system
(CNS) include a specialized and extreme form of cell
spreading in which oligodendrocytes extend large
lamellae that spiral around axons to form myelin. Recent
studies have demonstrated that laminin-2 (LN-2; 
 
 
 
2
 
 
 
1
 
 
 
1)
stimulates oligodendrocytes to extend elaborate membrane
sheets in vitro (cell spreading), mediated by integrin 
 
 
 
6
 
 
 
1.
Although a congenital LN-2 deﬁciency in humans is asso-
ciated with CNS white matter changes, LN-2–deﬁcient (
 
dy/
dy
 
) mice have shown abnormalities primarily within the
peripheral nervous system. Here, we demonstrate a critical
E
 
role for LN-2 in CNS myelination by showing that 
 
dy/dy
 
mice have quantitative and morphologic defects in CNS
myelin. We have deﬁned the molecular pathway through
which LN-2 signals oligodendrocyte cell spreading by dem-
onstrating requirements for phosphoinositide 3-kinase activ-
ity and integrin-linked kinase (ILK). Interaction of oligo-
dendrocytes with LN-2 stimulates ILK activity. A dominant
negative ILK inhibits LN-2–induced myelinlike membrane
formation. A critical component of the myelination signaling
cascade includes LN-2 and integrin signals through ILK.
 
Introduction
 
Formation of myelin is a function of oligodendrocytes in the
central nervous system (CNS) and Schwann cells in the
peripheral nervous system (PNS) in subtle interaction with
adjacent axons. To decipher the molecular mechanisms
involved in this process in the CNS, we have reduced myelin-
ation to three fundamental but likely interrelated cell biological
mechanisms: (1) a “cell spreading” machinery to form the
large surface membrane characteristic of differentiated oligo-
dendrocytes; (2) specific cell-cell recognition molecules that
stabilize oligodendrocyte–axon interactions; and (3) a
molecular motor that drives spiraling of the oligodendro-
cyte’s leading edge around the axon.
Here, we have focused on cell spreading, which involves
the elaboration of large membrane sheets, and on the genesis
of specialized sites on the cell surface for contact with axons.
Clues to the molecular mechanisms involved have come
from previous studies, which showed that laminin-2 (LN-2;
 
 
 
2
 
 
 
1
 
 
 
1), also called merosin, promotes extensive membrane
production by oligodendrocytes through integrin 
 
 
 
6
 
 
 
1 in
vitro (Buttery and ffrench-Constant, 1999). Importantly,
LN-2 is expressed on the axonal surface in the developing
CNS (Colognato et al., 2002), whereas in the developing
PNS, it is expressed in the basal lamina. Furthermore, in the
PNS, integrin 
 
 
 
1–null Schwann cells migrate, proliferate
and survive, but have a defect in the ensheathment of axons
and formation of myelin (Feltri et al., 2002). These results
prompted us to ask whether LN-2 and integrin 
 
 
 
1 might
also be important for cell spreading and myelination by
CNS oligodendrocytes.
Consistent with the studies described above, congenital
LN-2 deficiency in humans is associated with CNS white
matter changes as shown by magnetic resonance imaging
(Farina et al., 1998). However, LN-2–deficient 
 
(Lama2
 
dy
 
)
mice (formerly symbolized as 
 
dy
 
, dystrophia muscularis, or
 
mer
 
, merosin; we refer to the affected homozygotes hereafter
as, 
 
dy/dy
 
) have been reported to exhibit primarily a neuro-
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muscular phenotype including peripheral nerve hypomy-
elination and dysmyelination, with little evidence of de-
fects in CNS myelination (Tsuji and Matsushita, 1985;
Matsumura et al., 1997). The 
 
 
 
1 integrin signal can
function through integrin-linked kinase (ILK), a 59-kD
multidomain focal adhesion (FA) protein, which func-
tions as a molecular scaffold at cell-ECM adhesion sites
and participates in signal transduction pathways that con-
trol cell survival, differentiation, morphology, prolifera-
tion, and gene expression in mammalian cells (Wu and
Dedhar, 2001). Within FA complexes, ILK can interact
with other FA proteins such as paxillin, affixin, and CH-
ILKBP (Tu et al., 2001). In 
 
Caenorhabditis elegans
 
 and
 
Drosophila melanogaster
 
, loss of function mutations in
ILK and integrin-null mutations result in comparable
phenotypes (Zervas et al., 2001; Mackinnon et al., 2002).
The activation of ILK is phosphoinositide 3-kinase (PI3K)
dependent, with PI 3,4,5-triphosphate, a PI3K lipid pro-
duct, binding to the pleckstrin homology-like domain of
ILK and activating its serine/threonine kinase activity
(Dedhar, 2000).
Here, we have further defined the phenotype of 
 
dy/dy
 
mice by identifying hypomyelination in small-diameter ax-
ons and dysmyelination in large-diameter axons within the
CNS. We have determined the relevant molecular signaling
steps for LN-2–induced oligodendrocyte cell spreading and
myelin formation in vitro. We show that PI3K activity is re-
quired for oligodendrocytes to extend large cytoplasmic
sheets, independent of effects on survival, and that ILK is lo-
calized within FA complexes of oligodendrocytes and physi-
cally associates with other FA proteins such as paxillin. In
vivo, ILK is expressed primarily in oligodendrocytes within
CNS white matter tracts. Finally, a dominant negative (DN)
functioning ILK mutant gene blocks formation of the giant
sheets of oligodendrocytes.
We conclude that 
 
dy/dy
 
 mice have defects in CNS my-
elination, and that the molecular events involved in oligo-
dendrocyte cell spreading and myelin formation include sig-
nal transduction cascades using LN-2, integrin 
 
 
 
1, PI3K,
ILK, and possibly AKT.
 
Results
 
dy/dy
 
 mice are myelin-deficient and have fewer 
mature oligodendrocytes
 
A mutation (
 
Lama2
 
dy
 
) in the laminin
 
-
 
 
 
2 chain gene causes
of LN-2 deficiency in 
 
dy/dy
 
 mice. These mice show hindleg
paralysis at 
 
 
 
3.5 wk. To test the hypothesis that LN-2 is
involved in CNS myelin formation, we first quantified to-
tal cell concentration and total mature oligodendrocyte cell
concentration in coronal hematoxylin and eosin (H&E)-
and CC1-stained sections, respectively, through the corpus
callosum (CC; Fig. 1 A). The CC1 antibody recognizes oli-
godendrocyte cell bodies without labeling myelin (Fuss et
al., 2000). We observed a normal concentration of total
cells and a 30% reduced concentration of CC1
 
 
 
 oligoden-
drocytes in the CC of 
 
dy/dy
 
 mice as compared with con-
trols at matched anatomical sites (P 
 
  
 
0.05; Fig. 1 B). De-
spite the normal total cell concentration, the total number
of cells was reduced, because the CC area was smaller in
the mutants (Fig. 1 A), and the number of mature oligo-
dendrocytes was reduced even more than was indicated by
the measured 30% reduction in concentration. The de-
crease in CC1
 
 
 
 oligodendrocytes was accompanied by a re-
duction in myelin basic protein (MBP) content on the
forebrain determined by immunoblot (Fig. 1 C). In con-
trast, MBP content in the spinal cord (SC) of 
 
dy/dy
 
 and
control mice was equivalent (Fig. 1 C).
Figure 1. dy/dy mice are myelin-deficient and have fewer mature 
oligodendrocytes in the CC. (A) Light micrographs of 6  m paraffin-
embedded coronal sections from 5-wk control (ctrl) and dy/dy mice 
(n   3 of each). A reduction in the CC thickness in dy/dy mice is ap-
parent (arrows). Total cells in the CC, a major axonal projection 
area of the forebrain, were stained by hematoxylin and eosin (H&E; 
top), and mature oligodendrocytes were immunostained for CC1 
(bottom). Bar, 100  m. (B) The total cell and mature oligodendrocyte 
numbers in the CC were counted in a grid of constant area at a fixed 
distance of 0.8 mm from the midline in 10 nonadjacent sections of 
ctrl and dy/dy mice. Although there is no significant difference in to-
tal cell concentration, there is a significant reduction in the concen-
tration of CC1
  oligodendrocytes in dy/dy CC (P   0.05, asterisks). Be-
cause the CC area is smaller in the (A) dy/dy mice, the total number of 
CC1
  cells in the dy/dy mice is reduced even  30%. (C) Immunoblot 
analysis of MBP content was performed in the brain and the SC of 
ctrl and dy/dy mice (n   3). MBP level is significantly reduced in the 
dy/dy brain, but not in SC, compared with controls. Relative MBP 
levels corrected for loading with  -tubulin are shown (P   0.005, as-
terisks). Results (B and C) are presented as  SEM; and comparisons 
by ANOVA are significant (indicated by asterisks).T
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Ultrastructural analysis of 
 
dy/dy
 
 mice: 
regional differences
 
The above results suggest a defect in forebrain myelination in
 
dy/dy
 
 mice. To determine whether myelin structure as well as
myelin content is compromised, we analyzed by EM sagittal
sections of CC (Fig. 2), transverse sections of optic nerve
(ON; Fig. 3), and corticospinal tract in transverse sections of
cervical SC (Fig. 3). In the CC, we divided myelinated axons
into large diameter (axons 
 
 
 
 0.5 
 
 
 
m), and small diameter
(axons 
 
  
 
0.5 
 
 
 
m) groups and observed 
 
 
 
30% reduction in
the number of small diameter axons per unit area that were
myelinated in 
 
dy/dy
 
 mice (P 
 
  
 
0.005; Fig. 2, A and B). The
total number of axons per unit area was not changed (Table
I). Higher magnification revealed that 
 
 
 
40% of myelinated
axons in 
 
dy/dy
 
 mice showed ultrastructural abnormalities
(P 
 
  
 
0.0001) with large pockets of oligodendrocyte cyto-
Figure 2. dy/dy mice have dysmyelinated axons in the CC and 
reduced myelin sheath thickness. (A) Electron micrographs from the 
genu of the CC, in midline sagittal sections of ctrl and dy/dy mice at 
5 wk old (n   3). Axons in the CC are hypomyelinated in dy/dy 
mice (top), and there are fewer small myelinated axons ( 0.5  m, 
arrows). Bar, 1  m. Higher magnification (bottom) shows dysmy-
elination in the majority of dy/dy fibers (asterisks), consisting of non-
compacted regions in which myelin lamella are separated by pockets 
of oligodendrocyte cytoplasm, whereas similarly processed controls 
show well-developed compact myelin (arrows). Bar, 300 nm. (B) 
Total number of axons, myelinated axons, large axons (axonal 
diameter;  0.5  m) and small axons ( 0.5  m) were counted in 20 
randomly selected, nonoverlapping fields from mid-sagittal sections 
through the genu of the CC. The total number of axons per unit area 
and the number of large and small myelinated axons are presented 
as percentages of control. The percentage of small myelinated axons 
is  30% reduced in dy/dy mice (P   0.005, asterisk). (C) The per-
centage of dysmyelinated myelin sheaths is plotted. Almost 40% 
of the myelinated axons show noncompacted regions of myelin in 
dy/dy mice (P   0.0001, asterisks), compared with controls. 
(D) Mean g-ratio (axon diameter/myelinated fiber diameter) was 
assessed for large axons. The ratio in dy/dy mice is substantially 
different from controls (P   0.0001, asterisks), because even the 
large axons have abnormally thin myelin sheaths in the mutants. 
Results (B–D) are presented as  SEM; and comparisons by ANOVA 
are significant (indicated by asterisks).
Figure 3.  dy/dy mice show dysmyelinated axons also in the ON, 
but not in the SC. (A) Electron micrographs of the intracranial portion 
of the ON and the cervical corticospinal tracts of the SC from 5-wk 
control and dy/dy mice (n   3). The ON in dy/dy (top right) contains 
numerous axons with dysmyelinated sheaths (asterisks), and myelin 
sheath thickness appears reduced for axons of all calibers. In contrast, 
the compactness and thickness of myelin lamellae appear indistin-
guishable from normal in the SP of dy/dy mice (bottom). Bars: (top) 
1  m; (bottom) 4  m. (B) The concentration of myelinated axons 
was counted in 20 randomly selected, nonoverlapping fields from 
sections through the ON and SC. The total number of axons per unit 
area in dy/dy mice is expressed as percentages of the controls (ctrl). 
There are no differences in myelinated axon concentration in the 
ON or SC of ctrl and dy/dy mice. Results are presented as  SEM; 
and ANOVA revealed no statistical differences. (C) Percentages of 
dysmyelinated sheaths are shown. The ON of dy/dy mice contain 
 15% dysmyelinated axons, a significant increase over the controls 
(P   0.05, asterisks). No significant dysmyelination is observed in 
the SC of dy/dy mice. (D) Mean g-ratio in dy/dy mice is significantly 
different from controls (P   0.001, asterisks). No decrease is 
observed in the abundance of myelin sheaths and no morphological 
deficits are found in the SC of dy/dy mice. Results (C and D) are pre-
sented  SEM; and comparisons by ANOVA are significant (indi-
cated by asterisks).T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
400 The Journal of Cell Biology | Volume 163, Number 2, 2003
plasm separating myelin lamellae (Fig. 2, A and C). Mean my-
elin sheath thickness in dy/dy mice was  0.04  m compared
with the thickness of  0.09  m in controls (P   0.0001).
The average diameter of axons in control and dy/dy mice did
not differ significantly; the difference in mean g-ratio (axonal
diameter/total fiber diameter) of 0.82 for control fibers ver-
sus 0.91 in dy/dy mice (P   0.0001; Fig. 2 D) indicates my-
elin reduction in the mutants.
In the ON from dy/dy mice,  15% of the axons were dys-
myelinated compared with none in controls (P   0.05; Fig.
3, A and C). The total cross-sectional area of the nerve and
the number of myelinated axons per unit area were not
changed (Fig. 3 B), but the g-ratio was significantly in-
creased compared with controls (P   0.001; Fig. 3 D), to
the same extent as in the CC. In the SC, consistent with the
levels of MBP staining by immunoblot (Fig. 1 C), the total
number of myelinated axons (Fig. 3 B), myelin morphology
(Fig. 3 C) and myelin thickness (not depicted) were normal.
These results highlight the regional differences in myelina-
tion in dy/dy mice.
Responsiveness of oligodendrocytes to LN-2 in dy/dy 
mice: regional differences
Given the regional specificity of myelination abnormalities
in dy/dy mice, we next explored whether oligodendrocytes
from different regions of these mice show different behavior
on LN-2 in vitro. Although the mutation in dy/dy mice has
not yet been identified, these mice express small amounts of
apparently normal LN-2 in muscle, but no LN-2 in periph-
eral nerves (Guo et al., 2003). We cultured mixed glial cell
preparations from the CC region of the forebrain and from
the SC of postnatal (P) day 1 pups for 10 d and labeled cells
with mAb to galactocerebroside (O1).
10 and 5% of cells from the brain and the SC, respec-
tively, showed O1 immunoreactivity. The dy/dy pups were
distinguished from  /  and  /dy littermates in immuno-
blots by showing markedly reduced levels of LN-2 (M-chain)
in the sciatic nerve (SN) and mixed glial cultures of the
brain, respectively, compared with controls (Fig. 4 A). The
dy/dy cells on poly-L-ornithine (PLO) generally failed to
show cell spreading, in dramatic contrast to those cultured
on LN-2 (Fig. 4. B). O1
  cells prepared from dy/dy brain on
LN-2 showed dramatically increased oligodendrocyte cell
spreading compared with those on PLO (P   0.0001) or
compared with O1
  cells from control brain on PLO (P  
0.05; Fig. 4 C). Although O1
  cells prepared from the SC of
dy/dy mice showed larger processes on LN-2 than on PLO or
Figure 4. Oligodendrocytes from dy/dy brain (CC) are 
more responsive to LN-2 than those from the dy/dy SC. 
(A) Levels of LN-2 (M-chain, 80kD) were detected by 
immunoblot. The lysates were prepared from the SN and 
10 d-mixed glial cell cultures from the CC area of brain 
and from the SC of P day 1 pups. The dy/dy mice show no 
LN-2 expression in the SN and reduced levels in the 
brain, compared with controls (n   3).  -Tubulin levels 
were detected as a control. (B) The mixed glial cells from 
the brain and SC were cultured in 2% FBS for 10 d on 
poly-L-ornithine (PLO) or LN-2 and stained for O1 (green), 
as a marker for maturing oligodendrocytes, and DAPI 
(blue) for nuclei. Bar, 100  m. 10 and 5% of cells from 
the brain and the SC showed O1
 , respectively. The dy/dy 
cells on PLO generally failed to show cell spreading, in 
dramatic contrast to those cultured on LN-2. (C) The relative 
percentages of O1
  cells with broad myelin membrane 
sheets were counted. In confirmation of the image data in 
B, O1
  cells prepared from dy/dy brain on LN-2 showed 
dramatically increased oligodendrocyte cell spreading 
compared with those on PLO (P   0.0001, asterisk) or 
compared with O1
  cells from control brain on PLO
(P   0.05, asterisks). Although O1
  cells prepared from 
the SC of dy/dy mice showed an increase on LN-2 than 
on PLO or control, the difference was not significant. 
Results are presented as  SEM; and comparisons by 
ANOVA are significant (indicated by asterisks).
Table I. Concentration of small diameter myelinated axons is 
decreased in dy/dy mice
Total axons/mm
2 Myelinated axons Unmyelinated axons
[L] [S] [L] [S]
ctrl 228   12.4 40   2.8 25   3.3 15   1.4 147   11.4
dy/dy 228   11.1 40   1.2 17   1.1 15   0.7 156   10.6
The number of large and small diameter axons that are myelinated and
unmyelinated (total axons) per unit area (mm
2) in the control and in the dy/dy
mice was counted. t test revealed a statistically significant reduction of
small myelinated axons in dy/dy mice (P   0.05). [L]   large diameter
axons ( 0.5  m); and [S]   small diameter axons (  0.5  m).T
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a control (Fig. 4 B), the difference was not significant (Fig. 4
C). These data show that oligodendrocytes from the brain
surrounding the CC were more responsive to LN-2 than
those from the SC.
LN-2 enhances myelin membrane formation 
in oligodendrocytes in vitro
To define the molecular mechanisms through which LN-2
may regulate myelination, we used the culture paradigm of
Buttery and ffrench-Constant (1999) in which ECM com-
ponents influence oligodendrocyte morphology. We plated
oligodendrocyte precursor cells (OPCs) on four different
types of ECM and labeled with oligodendrocyte-specific an-
tibodies to O1 and MBP.
O11 cells grown on LN-2 extended broad sheetlike
processes in contrast to cells on BSA, thrombospondin-1
(TSP-1), or tenascin-C (TN-C; Fig. 5 A), and the difference
was highly significant (P   0.0001; Fig. 5 B). Average O1
 
cell diameter with sheets was 140  m   10 in the LN-2–
treated cells compared with 90  m     15 in the other
ECMs-treated cells. In addition, LN-2 enhanced the per-
centage of MBP
  cells (P   0.0001) and increased the MBP
levels detected by immunoblot (Fig. 5 C; unpublished data).
The increase in number of O1
  cells bearing sheets was not
due to increased cell survival on LN-2. Cells were plated on
different ECMs for 6 h, 1 d, 2 d and 3 d and cell survival
was measured through the Live/Dead Cytotoxicity and the
Alamar blue assays. Both assays indicated no statistical dif-
ferences in survival between the substrates (Fig. 5 D).
LN-2 promotes oligodendrocyte cell spreading through 
PI3K, but not MAPK
Because PI3K is involved in integrin  1–mediated cell
spreading in various cell types, we hypothesized that LN-2
may enhance oligodendrocyte cell spreading through PI3K.
PI3K activity was determined by measuring activation of
AKT, a primary downstream substrate of PI3K. OPCs
were replated on different ECMs, and 45 min and 6 h
later the level of phosphorylation was determined by im-
munoblot with a phospho-AKT ser473 antibody (Fig. 6
A). LN-2, TSP-1, and TN-C all activated the phosphory-
lation of AKT at 45 min. However, LN-2 activated AKT
phosphorylation continuously up to 6 h in contrast to
other ECMs, suggesting that AKT phosphorylation might
be important for LN-2–induced cell spreading in oligo-
dendrocytes.
Because LN-2 promotes membrane production through
integrin  6 1 and both PI3K and MAPK pathways are acti-
vated by integrin  6 1, we sought possible involvement of
these two molecular pathways in the effects of LN-2 on oli-
godendrocytes in vitro. These pathways were disrupted with
small molecule inhibitors: 0.01  M wortmannin (irrevers-
ible PI3K inhibitor); 0.5  M LY294002 (reversible PI3K
inhibitor); and 4  M U0126 (MAPK/ERK inhibitor).
These inhibitors blocked the phosphorylation of AKT and
MAPK in a time-dependent manner (Fig. 6, B–D). Inhibi-
tors of PI3K but not MAPK pathways disrupted LN-2–
enhanced membrane sheet formation (Fig. 6 E). 30% of O1
 
cells on LN-2 formed broad myelin membrane sheets (Fig. 6
G). However, the inhibitors of PI3K blocked formation of
these sheetlike processes;  50% of cells with long processes
lacked membrane sheets (P   0.005). We found no influ-
ence of MAPK inhibitor on LN-2–induced cell spreading
(Fig. 6, E and G). Together, these results suggest that LN-2
promotes oligodendrocyte cell spreading through the PI3K
but not the MAPK pathway.
Because AKT is one of crucial downstream effectors of
PI3K, we examined the functional role of AKT in LN-2–
induced oligodendrocyte cell spreading by using a DN-
Figure 5. LN-2 promotes oligodendrocyte cell spreading in vitro. 
(A) Purified OPCs isolated from the rat forebrain were cultured in 
the presence of PDGF and basic FGF for 3 d. Cells were fixed after 
three further days of growth on BSA, LN-2, TSP-1, and TN-C in 
serum-free media with N2 supplement (N2). Cells were plated and 
stained for O1 (left, green) and DAPI (blue). Bar, 100  m. (B) The 
relative percentages of O1
  cells with broad myelin membrane 
sheets on different ECM substrates were scored. LN-2 increases the 
ratio of O1
  cells with myelin membrane sheets to the total number 
of O1
  cells. Results are presented as  SEM; and comparisons by 
ANOVA are significant at P   0.0001 (indicated by asterisks). Average 
diameter of O1
  cells with sheets is 140   20  m in the LN-2–treated 
cells, compared with 90   15  m in the other ECMs-treated cells. 
(C) MBP levels were detected by immunoblot. The cell lysates were 
prepared 3 d after plating on ECMs. The MBP level on LN-2, but not 
on other ECMs, is increased. (D) The effects of ECMs on cell survival 
for 3 d were measured by the Alamar blue assay. Cells were plated 
on the various ECMs and incubated for 6 h, 1 d, 2 d, or 3 d. Results 
are presented as  SEM; and ANOVA revealed no statistical differences 
in survival between the substrates.T
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AKT (kinase inactive), in which both phosphorylation sites
of (Thr308 and Ser473) were replaced by alanine (AA-
AKT; Kitamura et al., 1998). HA-epitope–tagged DN-AKT
was expressed in the cells after incubation with tetracy-
cline responsive promoter (TRE)-DN-AKT and tetracycline
(Tet)-controlled transactivator (tTA) for 3 d by adeno-
virus-mediated Tet–off inducible system. Although GFP
vector alone (20 multiplicity of infection [MOI])-trans-
fected O1
  cells on LN-2 formed 50% broad sheetlike
processes consistent with myelin membrane sheets in 3 d
(Fig. 6, F and H), TRE-DN-AKT(10 MOI) and tTA
(10  MOI)-transfected cells decreased LN-2 induced cell
spreading by nearly 75% (Fig. 6, F and H; P   0.0001).
However, additional incubation with 10  g/ml Tet turned
off the expression of DN-AKT, showing as much cell
spreading as with GFP-vector alone (Fig. 6, F and H). Fur-
thermore, there was no statistically significant difference
on cell survival between GFP-vector alone– and DN-
AKT–transfected cells, but addition of Tet increased cell
survival (Fig. 6 I, P   0.5). These results show that AKT
activation might be involved in LN-2–enhanced cell
spreading in oligodendrocytes.
ILK is localized in oligodendrocytes in vivo and in vitro
Because integrin-linked kinase (ILK), a multidomain FA
protein, is critically involved both in the adhesion of cells
to the ECM by interacting with integrin  1 and in signal
transduction in a PI3K-dependent manner, we hypothe-
sized that ILK is involved in LN-2 signaling of oligo-
dendrocyte cell spreading and myelination. To examine
Figure 6. Oligodendrocyte cell spreading promoted 
by LN-2 requires PI3K, not MAPK. (A) 45 min and 
6 h after cells were plated on BSA, LN-2, TSP-1 
and TN-C, phosphorylation of AKT was detected 
by immunoblot with AKT phospho-ser473 (pAKT) 
antibody. AKT levels were detected as controls. 
(B–D) The blocking effects of both 0.01  M 
wortmannin (wort) and 0.5  M LY294002 (PI3K 
inhibitors) on pAKT or of 4  M U0126 (MAPK/ERK 
inhibitor) on pMAPK at 15 and 45 min were shown 
by immunoblot. AKT or MAPK levels were detected 
as controls. (E) Cells were fixed after 3 d growth on 
LN-2 with various inhibitors at the same concen-
trations used in B–D, after pretreatment for 5 min 
before plating and staining by O1 (green) and DAPI 
(blue). Bar, 100  m. (F) OPCs were plated on LN-2 
and infected with GFP-vector (20 MOI) alone or a 
DN-AKT (10 MOI) in serum-free media with N2 for 
3 d by an adenovirus-mediated tetracycline (Tet)–
off inducible system. Double staining with O1 
(left, red) and GFP (left, green) or with O1 (middle 
and right, green) and HA-epitope–tagged DN-AKT 
(middle and right, red) delineates cells infected 
by vector or DN-AKT. Incubation of tetracycline 
responsive promoter (TRE)-DN-AKT (10 MOI) with 
tetracycline-controlled transactivator (tTA, 10 MOI) 
blocks LN-2–induced cell spreading by expression 
of DN-AKT. Incubation with 10  g/ml Tet turned 
off the expression of DN-AKT, showing cell 
spreading as much as GFP-vector alone. Bar, 100 
 m. (G) The relative percentage of O1
  cells with 
broad myelin membrane sheets on LN-2 with 
various inhibitors is shown. Treatment with PI3K 
inhibitors reduces myelin membrane formation up 
to 50% (P   0.005, asterisks). MAPK inhibitor had 
no influence on myelin membrane formation. 
(H) The relative percentage of O1
  cells with broad 
myelin membrane sheets is shown. Incubation of 
TRE-DN-AKT (10 MOI) with tTA (10 MOI) decreases 
cell spreading up to 75% compared with 20 MOI 
GFP-vector alone (P   0.0001, asterisks). Incubation 
with 10  g/ml Tet increases cell spreading up to 
50%. (I) Cell survival was measured by the Live/
Dead Cytotoxicity assay. There is no statistical 
difference in cell survival between vector alone 
(20 MOI) and TRE-DN-AKT (10 MOI)   tTA 
(10 MOI), whereas addition of Tet increases cell 
survival (P   0.05, asterisk). Results (G–I) are 
presented as  SEM; and comparisons by ANOVA 
are significant (indicated by asterisks).T
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whether ILK is expressed in oligodendrocytes, we double
stained for ILK and NG2 as a marker for OPCs or MBP
for mature oligodendrocytes (Fig. 7 A, arrows). Double
staining clearly shows that ILK is expressed principally in
interfascicular oligodendrocytes.
Next, we investigated ILK expression in vivo during
early myelination of rat PNS SN (P days 1–5) and rat CNS
ON (P7, P9–11, and P15) and in the CC and the ON of
5-wk control and dy/dy mice (Fig. 7 B). ILK was enriched
in the rat PNS, specifically in cytoplasmic processes of
Schwann cells at nodes of Ranvier. In the rat CNS ON,
ILK expression was restricted to interfascicular oligoden-
drocytes (Fig. 7 B, arrows). Sections double labeled with
ILK and Caspr, an axonal component of paranodal axoglial
junctions, showed that ILK protein was detected only in
oligodendrocytes from P9 onward, when myelination was
underway. Double staining with ILK and Caspr in the CC
and the ON of 5-wk control and dy/dy mice showed that
ILK in the adult mouse CNS, as in the developing rat
CNS, was localized to oligodendrocyte cell bodies (Fig. 7
C, arrows). There was no significant difference in the ILK
expression pattern between control and dy/dy mice. These
results indicate that ILK is expressed in myelinating cells in
rat and mouse PNS and CNS, and may be involved in gen-
eral in cell spreading in myelinating cells.
ILK shows colocalization with FA proteins such as 
integrin  1 and paxillin in oligodendrocytes
Given the reported role of ILK in adhesion complexes (Li et
al., 1999), we labeled oligodendrocytes for ILK and the FA
proteins integrin  1 and paxillin (Fig. 8 A). ILK was local-
ized in the cell body and throughout the processes including
their tips, with a high concentration of ILK at the growth
cone–like termini. Digitally merged images of differentiat-
ing oligodendrocytes on LN-2 demonstrate that ILK colo-
calizes with integrin  1 in cell bodies and at FA sites in pro-
cesses (Fig. 8 A, arrows).
Paxillin, a 68-kD FA adaptor molecule involved in integrin
signaling, functions in regulation of the actin cytoskeleton
(Turner, 2000). Like integrin  1, paxillin colocalized with
ILK in FAs (Fig. 8 A). We evaluated the interaction between
ILK and paxillin also by coimmunoprecipitation of ILK with
paxillin from lysates of cells grown on BSA, LN-2, and in
suspension (Fig. 8 B). The results suggest that the ILK–paxil-
lin interaction is constitutive rather than adhesion induced.
LN-2 stimulates ILK activity and DN-ILK blocks 
LN-2–induced myelin membrane formation
To determine the functional role of ILK in LN-2–induced oli-
godendrocyte cell spreading, we used a dominant negative ILK
Figure 7. ILK is expressed in the 
developing CNS and PNS. (A) Double 
staining for ILK (left, red) and NG2 (left, 
green) or MBP (right, green) in rat CNS 
ON. Most sites of NG2 immunoreactivity, 
including cell bodies (arrowhead) are 
devoid of ILK staining, although occa-
sionally NG2-positive cells are also ILK 
positive (arrow). In MBP-positive cells, 
The ILK staining is restricted to long 
rows of cells residing between fascicles 
of myelinated axons (arrow). Bar, 10 
 m. (B) ILK expression patterns during 
development of Sprague-Dawley rat SN 
(left, P days: P1–5) and of rat CNS ON 
(right, P7, P9–11, and P15). The SN 
shows localization of ILK (red) to the 
cytoplasm of Schwann cells at nodes 
of Ranvier (arrows) throughout the early 
P developmental phase. In the ON, ILK 
(red) is restricted to oligodendrocyte cell 
bodies (arrows), whereas the protein 
Caspr (green), restricted to paranodal 
axoglial junctions, serves as a marker 
of myelination. At P7, myelin has not 
yet formed, as evidenced by the lack of 
Caspr staining, and oligodendrocytes do 
not yet stain for ILK. From P9 onward, 
both stains are positive. Bars, 10  m. (C) 
Double staining with ILK (red) and Caspr 
(green) in the CC and ON of 5-wk con-
trol and dy/dy mice. ILK in the CC and 
the ON of these animals is localized to 
oligodendrocyte cell bodies. Expression 
pattern of ILK does not differ significantly 
between control and dy/dy mice, 
whereas there appears to be a difference 
in Caspr immunoreactivity, suggesting 
paranodal abnormalities. Bars, 10  m.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
404 The Journal of Cell Biology | Volume 163, Number 2, 2003
loss of function mutation in ILK (DN-ILK; kinase inactive),
in which Glu 359 was mutated to Lys (Persad et al., 2000).
When GFP-vector or GFP-DN-ILK was inserted into cells by
adenovirus-mediated gene transfer, 60% of cells expressed
GFP (unpublished data). Transfectants were replated on LN-2
in serum-free media and cultured for 1, 2, or 6 h. ILK activity
was determined with exogenous MBP as a substrate. LN-2 in-
duced ILK to phosphorylate MBP in GFP-transfected cells,
with a peak at 1 h, but not in cells expressing DN-ILK (Fig. 9
A). Furthermore, LN-2 stimulated ILK activity more effec-
tively than any of the other ECMs at 1 h (Fig. 9 B, P   0.5).
ILK also can phosphorylate PKB/AKT on ser473 directly
or indirectly (Delcommenne et al., 1998; Troussard et al.,
2003). DN-ILK blocked phosphorylation of AKT ser473
(Fig. 9 C). DN-ILK also inhibited phosphorylation of GSK-
3  on ser 9, a downstream substrate of ILK (unpublished
data). To test directly whether ILK is involved in LN-2–
enhanced oligodendrocyte cell spreading, DN-ILK was ex-
pressed in OPCs, which were plated on LN-2 and incubated
with vector or DN-ILK (10 or 20 MOI) for 3 d. As a con-
trol, we measured cell survival through the Live/Dead Cyto-
toxicity assay and found no significant cell death in DN-ILK
(10 MOI) compared with vector (10 MOI), but, at the
higher DN- ILK concentration of 20 MOI, we did find sig-
nificant cell death (Fig. 9 F).
Staining for O1 and DAPI revealed that 50% of GFP-
transfected O1
  cells (10 or 20 MOI) formed broad sheetlike
processes consistent with myelin membrane sheets (Fig. 9, D
and E). In DN-ILK transfected cells, formation of these sheet-
like processes was decreased by nearly 80% (P   0.001).
Only 10% of cells transfected with 10 MOI DN-ILK formed
membrane sheets, and an even smaller percentage with 20
MOI DN-ILK (Fig. 9, D and E). These results demonstrate
that ILK is necessary for LN-2 signaling in oligodendrocyte
cell spreading and myelin formation. In summary, LN-2–
induced oligodendrocyte cell spreading and myelination in
CNS occurs in a PI3K/ILK-dependent manner.
Discussion
LN-2 is required for normal myelination in the CNS
Although congenital LN-2 deficiency in humans leads to
CNS white matter changes as detected by magnetic reso-
nance imaging as well as peripheral neuropathy and muscu-
lar dystrophy (Morandi et al., 1999), dy/dy mice with spon-
taneously occurring mutations in LN-2 were reported to
exhibit phenotypic abnormalities limited to PNS myelina-
tion and skeletal muscle (Bradley and Jaros, 1979), except
for the report of CNS myelin abnormalities in mice by Tsuji
and Matsushita (1985). Here, we analyzed 5-wk-old dy/dy
and littermate control mice for possible involvement of this
gene in CNS myelination. In the CC of dy/dy mice, we
found (1) reduced thickness of the CC; (2) a 30% reduction
in the concentration of mature oligodendrocytes without a
Figure 8. ILK is expressed in oligoden-
drocytes in vitro and colocalizes with 
the FA-associated molecules, integrin 
 1 and paxillin. (A) OPCs isolated from 
P2 Sprague-Dawley rat forebrain were 
stimulated to differentiate in vitro, and 
cells were double stained with ILK 
(green) and integrin  1 (red) or paxillin 
(red) in differentiated oligodendrocytes 
plated on LN-2. ILK is distributed 
throughout the cell body and processes, 
including the tips of processes (top left) 
and growth cone–like termini (bottom 
left) of oligodendrocytes. Higher magni-
fication of merged images (the boxed 
areas) demonstrates that ILK colocalizes 
with integrin  1 and paxillin in FAs 
(arrows). Although integrin  1 is partly 
colocalized with ILK throughout the cell 
body and processes, paxillin colocalizes 
with ILK in every part of the cell. Bar, 30 
 m. (B) OPCs were plated and then 
incubated for 30 min either with ECMs 
(BSA and LN-2 [with or without IgG]) 
or without ECMs (Ctrl) and were lysed in 
NP-40 lysis buffer. Paxillin and control 
mouse IgG immunoprecipitations were 
performed and subjected to SDS-PAGE 
followed by immunoblot with antibodies 
against ILK. ILK coimmunoprecipitates 
with the paxillin antibody as compared 
with the control IgG. Total amounts of 
lysates were detected by antipaxillin 
antibody. The results suggest that the 
ILK–paxillin interaction is constitutive 
rather than adhesion induced.T
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change in total glial cell concentration; and (3) defects in
myelin lamellar compaction and sheath thickness. These re-
sults agree with previous studies (Buttery and ffrench-Con-
stant, 1999) showing that LN-2 promotes formation of my-
elin membrane in vitro and further suggest that dy/dy mice
may show developmental defects expressed as a disturbance
in lamellar organization or oligodendrocyte cell volume.
However, these results may also reflect a decrease in oligo-
dendrocyte survival.
Small-sized axons are preferentially affected
Hypomyelination is particularly evident in small-sized ax-
ons. We found an  30% reduction in the concentration of
small-sized ( 0.5  m) axons that were myelinated in dy/dy
CC, whereas the total number of myelinated axons in the
same area was not changed. The preferential reduction in
myelination of small-sized axons may reflect an inability of
individual oligodendrocytes to extend multiple cytoplasmic
processes and envelope a cluster of small- sized axons, with-
out a corresponding defect in their ability to wrap around
large-sized axons (Bjartmar et al., 1994). Oligodendrocyte
cell bodies might lie closely associated with large-sized ax-
ons, without a requirement to reach them by extending cy-
toplasmic processes (Hildebrand et al., 1993). Accordingly,
impaired formation of oligodendrocyte processes and mem-
brane sheets would cause a more pronounced hypomyelina-
tion in tracts rich in small-sized axons than in tracts with
large-sized axons. Another possible explanation for the dif-
ferences between the abnormalities in small- and large-sized
axons is that myelination may be delayed in the CNS of dy/
dy mice, as it is in the PNS, because large-sized axons are
generally myelinated earlier than small-sized axons in the
CNS (Schwab and Schnell, 1989).
Regional differences
The dramatic differences between PNS and CNS myelina-
tion in the spontaneous dy/dy mutant mouse, described by
several investigators approximately three decades ago (Brad-
ley and Jaros, 1979), merit reconsideration. In segments of
nerve roots of almost all cranial nerves and segments of both
dorsal and ventral roots of cervical, lumbar, and sacral spinal
nerves examined by EM, large clusters of small diameter ax-
ons are completely unmyelinated and lie contiguous with
one another, without intervening Schwann cell cytoplasmic
strands. Given that the gene product, LN-2, is a surface
membrane constituent of axons, it now seems clear that the
myelination problem at these restricted sites results not from
a deficient number of Schwann cells caused by reduced cell
division or excessive cell death, but from a failure of my-
elinating cells in the PNS and CNS to respond to the  1 com-
ponent of LN-2 via PI3K and ILK by extending cytoplasmic
Figure 9. LN-2 activates ILK activity and DN-ILK inhibits oligo-
dendrocyte cell spreading. (A) OPCs were transfected with 10 MOI 
vector alone as a control or with DN-ILK (kinase-inactive form of 
ILK) by adenovirus gene transfer. After 24 h, transfectants were 
plated on LN-2 in serum-free media with N2 and cultured for the 
indicated time periods. ILK was immunoprecipitated from cell 
extracts. ILK activity was determined with MBP as an exogenous 
substrate. Total amounts of ILK proteins in the immunoprecipitates 
were detected by immunoblot with an anti-ILK antibody. Results 
indicate that LN-2 stimulates ILK activity. (B) 1 h after cells were 
plated on BSA, LN-2, TSP-1, and TN-C. ILK activity was detected by 
phosphorylation of MBP. ILK levels were detected as controls. LN-2 
stimulates ILK activity more effectively than any of the other ECMs 
at 1h (P   0.5) (C) The blocking effect of DN-ILK on pAKT ser473 
was investigated by immunoblot. Cells were plated on LN-2 and 
incubated with 10 MOI vector or 10 or 20 MOI DN-ILK for 3 d. 
Compared with vector, DN-ILK blocks phosphorylation of AKT 
ser473. AKT and  -tubulin serve as standards for the total amount 
of protein. (D) OPCs were plated on LN-2 and incubated with 10 
or 20 MOI GFP-vector or GFP-DN-ILK in serum-free media with 
N2 for 3 d. Cells were fixed and stained for O1 (red) and with DAPI 
for nuclei (blue). Double staining with O1 and GFP (top) or with O1 
and DAPI (bottom) delineates cells infected by vector or DN-ILK. 
DN-ILK blocks LN-2–induced cell spreading. Bar, 100  m. (E) The 
relative percentage of GFP-expressing O1
  cells with broad myelin 
membrane sheets is shown. 20 MOI DN-ILK decreases cell spreading 
up to 75% compared with vector alone (P   0.005, asterisks). 
(F) Cell survival was measured by the Live/Dead Cytotoxicity assay. 
There is no statistical difference in cell survival between 10 MOI 
vector and 10 MOI DN-ILK, whereas 20 MOI DN-ILK induces cell 
death (P   0.01, asterisks). (E and F) Results are presented as  SEM; 
and comparisons by ANOVA are significant (indicated by asterisks).T
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sheets, which are to envelop axons and form myelin lamel-
lae. An unresolved problem is why myelination in the PNS
is essentially normal in the few millimeters of the nerve roots
closest to the SC, as well as throughout nerves distal to the
roots, but grossly abnormal in relatively short intervening
segments of the roots. This is a general problem with neuro-
logical genetic diseases, which commonly show a remarkable
selectivity within what we generally assume to be a uniform
population of target cells.
Here, we found regional differences in myelination and
oligodendrocyte cell spreading within the CNS: (1) SC
corticospinal tracts exhibited no reduction in myelin con-
tent and no dysmyelination, in contrast to the ON and
CC, which were hypomyelinated and showed many dys-
myelinated axons; and (2) Oligodendrocytes of the SC are
less responsive to LN-2 than those of the CC. These data
suggest that LN-2 might be a crucial factor for myelination
only in selected areas of the CNS. Interestingly, Fyn-
knockout mice exhibit a pattern of regional differences
within the CNS similar to what we have found in dy/dy
mice (Sperber et al., 2001).
LN-2 signaling in oligodendrocyte cell spreading 
is PI3K dependent
We observed that LN-2, TSP-1, and TN-C all activated the
phosphorylation of AKT at 45 min. However, for the anti-
adhesive proteins, TSP-1 and TN-C, PI3K and AKT activa-
tion is transient. LN-2 activated AKT phosphorylation
continuously for up to 6 h, suggesting that sustained AKT
phosphorylation might be important for LN-2–induced cell
spreading in oligodendrocytes. A role for AKT phosphoryla-
tion is also supported by our data that DN-AKT expression
in an adenovirus-mediated Tet–off inducible system de-
creased LN-2–induced cell spreading. However, longer-term
AKT activation remains to be examined.
PI3K, but not MAPK, participates in LN-2–enhanced my-
elin membrane sheet formation in oligodendrocytes in vitro.
Previous findings had suggested that PI3K is involved in the
regulation of actin cytoskeleton organization during integrin-
mediated cell spreading (Seger et al., 2001). We show that
PI3K inhibitors at concentrations (0.01  M wortmannin
and 0.5  M LY294002) that do not affect cell viability pre-
vent the formation of the LN-2–induced giant lamellae char-
acteristic of oligodendrocytes, but do not change the number
of O1
 cells. One reason why PI3K inhibitors might not af-
fect cell survival on LN-2 is because LN-2 may switch in sur-
vival signaling, from PI3K to MAPK pathway in mature oli-
godendrocytes (Colognato et al., 2002).
Our results are supported by previous data showing that
TSP-1 influences the migration (Scott-Drew and ffrench-
Constant, 1997) and TN-C promotes proliferation (Gar-
cion et al., 2001), but not differentiation through  v 1
and  v 3, respectively, in oligodendrocytes. In our short-
term culture system, this LN-2–enhanced myelin mem-
brane formation was not related to cell survival. However,
previous studies have reported that LN-2 can function as a
survival cue for mature oligodendrocytes (Colognato et
al., 2002), and we cannot rule out the possibility that LN-2
in long-term culture might support oligodendrocyte cell
survival.
ILK plays a critical role in oligodendrocyte 
cell spreading
Here, we show ILK expression in the CNS in vivo at high
levels in interfascicular oligodendrocytes, with a time course
that parallels myelination (Domercq et al., 1999). Because
LN-2 is expressed on axons at the time of myelination (Pow-
ell et al., 1998), ILK may play an important role in LN-2–
induced CNS myelination. Also, in the SN of the PNS, ILK
was most prominent in Schwann cell cytoplasm, especially at
and near nodes of Ranvier. Consistent with the in vivo data,
we find that ILK is enriched in FAs in oligodendrocytes in
vitro. Recently, ILK-deficient mice have been reported to
die at the peri-implantation stage because of abnormal accu-
mulation of actin at sites of integrin attachment at the base-
ment membrane zone, and ILK-deficient fibroblasts show
impaired cell spreading and delayed formation of FAs (Sakai
et al., 2003). This implies a role for ILK in regulation of the
actin cytoskeleton, which might be implicated in oligoden-
drocyte cell spreading. Furthermore, paxillin is important
in regulation of the actin cytoskeleton in Schwann cells
through integrin  1 (Taylor et al., 2003) and ILK colocal-
izes with paxillin in FAs (Nikolopoulos and Turner, 2001).
We found that ILK is colocalized with integrin  1 and is as-
sociated with paxillin in FAs of differentiated oligodendro-
cytes on LN-2.
We also show that LN-2 stimulates ILK activity in oligo-
dendrocytes and that the inhibition of ILK by DN-ILK
blocks myelin membrane formation induced by LN-2. The
interaction of the kinase domain of ILK with integrin  1,
paxillin and PKB/AKT suggests that integrin  1, paxillin
and PKB/AKT might be important regulators of the ILK-
mediated signaling pathway for LN-2–induced oligodendro-
cyte cell spreading. Another possible mechanism through
which ILK might influence oligodendrocyte cell spreading is
suggested by the multidomain structure and FA localization
of ILK, which imply that ILK might function as a scaffold-
ing protein mediating multiple protein–protein interactions
(Tu et al., 2001).
A distinction between hypomyelination 
and dysmyelination
Maturation of oligodendrocytes is a complex process that we
have divided, in an attempt to unravel a temporal series
of molecular control mechanisms, into arbitrary “stages”,
which include cell spreading, axonal ensheathment, and my-
elin compaction. We have shown that the dy/dy mouse has a
reduced number of mature oligodendroglial cells and fea-
tures hypomyelination and dysmyelination in several CNS
tracts. ILK appears to be involved in the LN-2/integrin sig-
naling that promotes the early maturational events of cell
spreading and process formation. Hypomyelination is an ex-
pected consequence, but the basis for the dysmyelination
component of the dy/dy phenotype remains to be elucidated.
Many additional genes are also involved in oligodendrocyte
maturation. Among them, the nonreceptor-type tyrosine ki-
nase Fyn, a member of the src family, has been identified as
a signaling molecule downstream of L-MAG (Umemori et
al., 1994). Analysis of Fyn / , MAG / , and Fyn/MAG
double knockout mice indicates that Fyn is involved in oli-
godendrocyte membrane and process formation, and MAGT
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in the formation of compact CNS myelin (Biffiger et al.,
2000). There may be direct or indirect interactions of the
ILK–LN-2–integrin components and the related FA pro-
teins with Fyn, MAG, and additional molecular mediators.
Materials and methods
Animals
Homozygous 129/ReJ dy/dy mice and control littermates 5 wk old were
purchased from The Jackson Laboratory. Dystrophic mice were distin-
guished from their littermates at 2–3 wk old, when they began to exhibit
hindleg weakness. The  /  and  /dy littermates were pooled as controls.
Reagents
LN-2, TN-C, and laminin- 2 chain (M-chain) antibody were obtained from
CHEMICON International Inc.; PLO was obtained from Sigma-Aldrich;
TSP-1 and ICN were obtained from Biomedicals; purified BSA was ob-
tained from New England Biolabs, Inc.; wortmannin and LY294002 (PI3 K
inhibitors) were obtained from Calbiochem; mAbs against A2B5, O4, and
O1 were obtained from American Type Culture Collection; monoclonal
and polyclonal anti-ILK and monoclonal anti–integrin  1, antipaxillin, and
anti– -tubulin antibodies and MBP were obtained from Upstate Biotech-
nology; antibody against MBP SMI99 was obtained from Sternberger Mono-
clonals; polyclonal antibodies against phospho-AKT ser473, AKT, phos-
pho–GSK-3 ser9, and U0126 (MAPK inhibitor) were obtained from Cell
Signaling; monoclonal CC1 antibody was obtained from Oncogene Re-
search Products; secondary antibodies were obtained from Jackson Immu-
noResearch Laboratories; Alamar blue assay kit was obtained from Treck
Diagnostics; and the Live/Dead viability/Cytotoxicity assay kit was ob-
tained from Molecular Probes.
Primary oligodendrocyte cultures
Primary cultures of OPCs were prepared from the cerebral hemispheres of
2-d-old Sprague-Dawley rats as described previously (Vartanian et al.,
1997). Purified OPCs were plated on PLO-coated 60-mm dishes and incu-
bated in the presence of 10 ng/ml PDGF and basic FGF for 3 d. To produce
differentiated oligodendrocytes, cells were plated on different ECM sub-
strates after trypsinization for 8–10 min and incubated in serum-free media
with N2 supplement (N2) for another 3 d. Various ECMs, 10  g/ml BSA, 1
 g/ml LN-2, 15  g/ml TSP-1, and 3  g/ml TN-C were incubated in PLO-
coated 24-well dishes at 37 C for 1 h and washed three times with PBS.
Immunofluorescence microscopy
Immunofluorescence staining for A2B5, O4, or O1 was performed as de-
scribed previously (Park et al., 2001). For the staining of FA proteins such
as ILK, integrin  1, or paxillin, cells plated on LN-2 were extracted with
0.5% Triton-X 100 buffer before fixation. ONs from rats and control and
dy/dy mice were dissected and immediately fixed in ice cold 4% PFA in
0.1 M phosphate buffer, pH 7.2, for 30 min. Fixed tissue was transferred to
ice cold 20% sucrose (wt/vol) in 0.1 M phosphate buffer until equilibrated.
Immunofluorescence staining was performed as described previously (Ras-
band et al., 1999). Immunofluorescent images were obtained with an ob-
jective (model Eclipse 660; Nikon) on 35-mm color film (ASA 400; Kodak),
and digitized with a slide scanner or on an Axioskop 2 (Carl Zeiss Micro-
Imaging, Inc.) fitted with a digital camera (model ORCA-ER; Hamamatsu).
Immunoblot
Primary cells were lysed in NP-40 lysis buffer (1% NP-40, 150 mM NaCl,
0.25% deoxycholate, 1 mM EGTA, 1 mM NaF, 50 mM Tris-HCl, 1 mM
PMSF, and 2 mM sodium orthovanadate). For immunoblot analysis, cells
were lysed in SDS sample buffer, boiled and subjected to SDS-PAGE fol-
lowed by immunoblot. Incubation with primary antibodies was performed
overnight at 4 C. For detection, HRP-conjugated secondary antibodies
were used (1:5,000), followed by ECL development (Amersham Bio-
sciences). 5-wk dy/dy and control mice were killed by CO2 inhalation; the
forebrain and the SC were removed and tissue homogenates were pre-
pared in the lysis buffer. Blots were detected by primary antibodies such as
MBP (1:1,000), ILK (1:1,000), and  -tubulin (1:1,000).
Coimmunoprecipitation
Lysates were prepared in serum-free media with N2 for 30 min from either
OPCs that had been incubated on different ECMs such as BSA and LN-2 or
OPCs in suspension after trypsinization. Lysates prepared in NP-40 lysis
buffer were incubated with antipaxillin antibody and protein G–agarose
overnight at 4 C. After washing and boiling the beads, immunoprecipitates
in SDS sample buffer were separated by electrophoresis on 10% SDS-
PAGE, transferred to membranes, and probed with anti-ILK or paxillin anti-
bodies. Kinase assay for ILK activity was performed as described previ-
ously (Ishii et al., 2001).
Viability studies
Cell survival was quantified by two rapid biochemical assays, the Alamar
blue and Live/Dead Cytotoxicity assays. The Alamar blue assay (AccuMed
International) was performed as described previously (Back et al., 1999).
The Live/Dead Cytotoxicity assay is based on use of two probes, calcein
AM and ethidium homodimer.
Adenovirus transfection
In the adenovirus-mediated Tet-off inducible system, infection of cells
grown on LN-2 for 3 d with the recombinant TRE-adenovirus containing
the pcDNA encoding HA-tagged DN-AKT (kinase inactive) with adeno-
viral tetracycline (Tet)-controlled transactivator (tTA) induced the expres-
sion of DN-AKT, and tetracycline (Tet) turned off its expression. ILK plas-
mids were provided by Shoukat Dedhar (Jack Bell Research Centre,
Vancouver, Canada).
We generated recombinant GFP-adenovirus containing the pcDNA en-
coding either ILK or V5-His tagged-DN-ILK (kinase inactive). Cells that ex-
pressed GFP were assumed to be expressing the protein of interest. OPCs
were plated on LN-2 and incubated with 10 or 20 MOI GFP-vector or
GFP-DN-ILK in serum-free media with N2 for 3 d. The infection rate of re-
combinant adenovirus GFP-ILK and GFP-DN-ILK was determined by the
MOI that was expressed as the number of plaque forming units per cell.
Immunohistochemical staining
Mice were perfused with 4% PFA and held overnight in the same fixa-
tive. Segments of brain were embedded in paraffin and sectioned at 6
 m. The total cell concentration was counted in sections stained with
H&E. Mature oligodendrocytes in the CC were identified in 6  m paraf-
fin sections incubated at 4 C overnight with CC1 (1:5). CC1 immunore-
activity was detected with the ABC Elite Kit for mouse (Vector Laborato-
ries) with DAB substrate.
EM
Mice were anesthetized with CO2 gas and perfused transcardially with
0.9% NaCl, followed by 2% PFA and 2.5% glutaraldehyde in 0.1 M ca-
codylate buffer, pH 7.4. Brain, ON, and cervical SC were then removed,
trimmed, and held overnight in the same fixative. Tissue blocks were
washed in 0.1 M cacodylate buffer, pH 7.4, and incubated for 1.5 h in 1%
osmium tetroxide/1.5% potassium ferrocyanide, washed in H2O, followed
by maleate buffer, pH 5.2, and incubated for 1 h in 1% uranyl acetate in
maleate buffer, pH 5.1. Blocks were washed in maleate buffer, dehydrated
in graded ethanols, followed by propylene oxide, and embedded in TAAB
Epon. Sections for light microscopy were cut at 0.5  m and stained with
alkaline toluidine blue. Ultrathin sections for EM were stained with uranyl
acetate and lead citrate, and examined with a transmission electron micro-
scope (model 1200EX; JEOL).
We thank Pieter Dikkes for technical assistance, and Jacob A. Sloane and
N. Abimbola Sunmonu for their helpful comments with the manuscript. 
This work was supported by grants from the National Institute of Neuro-
logic Disorders and Stroke, R01 NS044916 to M.N. Rasband and R01
NS42317, K02 NS02028, and P01 NS38475 to T. Vartanian.
Submitted: 29 April 2003
Accepted: 8 September 2003
References
Back, S.A., R. Khan, X. Gan, P.A. Rosenberg, and J.J. Volpe. 1999. A new Alamar
blue viability assay to rapidly quantify oligodendrocyte death. J. Neurosci.
Methods. 91:47–54.
Biffiger, K., S. Bartsch, D. Montag, A. Aguzzi, M. Schachner, and U. Bartsch.
2000. Severe hypomyelination of the murine CNS in the absence of myelin-
associated glycoprotein and fyn tyrosine kinase. J. Neurosci. 20:7430–7437.
Bjartmar, C., C. Hildebrand, and K. Loinder. 1994. Morphological heterogeneity
of rat oligodendrocytes: electron microscopic studies on serial sections. Glia.
11:235–244.
Bradley, W.G., and E. Jaros. 1979. Involvement of peripheral and central nerves inT
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
408 The Journal of Cell Biology | Volume 163, Number 2, 2003
murine dystrophy. Ann NY Acad Sci. 317:132–142.
Buttery, P.C., and C. ffrench-Constant. 1999. Laminin-2/integrin interactions en-
hance myelin membrane formation by oligodendrocytes. Mol. Cell. Neurosci.
14:199–212.
Colognato, H., W.V. Baron, V. Avellana-Adalid, J.B. Relvas, A. Baron-Van Ever-
cooren, and E. Georges-Labouesse, and C. ffrench-Constant. 2002. CNS in-
tegrins switch growth factor signaling to promote target-dependent survival.
Nat. Cell Biol. 41:883–841.
Dedhar, S. 2000. Cell-substrate interactions and signaling through ILK. Curr.
Opin. Cell Biol. 12:250–256.
Delcommenne, M., C. Tan, V. Gray, L. Rue, J. Woodgett, and S. Dedhar. 1998.
Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase
kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc. Natl.
Acad. Sci. USA. 95:11211–11216.
Domercq, M., M.V. Sanchez-Gomez, P. Areso, and C. Matute. 1999. Expression
of glutamate transporters in rat optic nerve oligodendrocytes. Eur. J. Neuro-
sci. 11:2226–2236.
Farina, L., L. Morandi, I. Milanesi, E. Ciceri, M. Mora, I. Moroni, C. Pantaleoni,
and M. Savoiardo. 1998. Congenital muscular dystrophy with merosin defi-
ciency: MRI findings in five patients. Neuroradiology. 40:807–811.
Feltri, M.L., D. Graus Porta, S.C. Previtali, A. Nodari, B. Migliavacca, A. Cassetti,
A. Littlewood-Evans, L.F. Reichardt, A. Messing, A. Quattrini, U. Mueller,
and L. Wrabetz. 2002. Conditional disruption of beta 1 integrin in Schwann
cells impedes interactions with axons. J. Cell Biol. 156:199–209.
Fuss, B., B. Mallon, T. Phan, C. Ohlemeyer, F. Kirchhoff, A. Nishiyama, and W.B.
Macklin. 2000. Purification and analysis of in vivo-differentiated oligoden-
drocytes expressing the green fluorescent protein. Dev. Biol. 218:259–274.
Garcion, E., A. Faissner, and C. ffrench-Constant. 2001. Knockout mice reveal a
contribution of the extracellular matrix molecule tenascin-C to neural pre-
cursor proliferation and migration. Development. 128:2485–2496.
Guo, L.T., X.U. Zhang, W. Kuang, H. Xu, A. Liu, J.T. Vilquin, Y. Miyagoe-
Suzuki, S. Takeda, M.A. Ruegg, U.M. Wewer, and E. Engvall. 2003. Lami-
nin alpha2 deficiency and muscular dystrophy; genotype-phenotype correla-
tion in mutant mice. Neuromuscul. Disord. 13:207–215.
Hildebrand, C., S. Remahl, H. Persson, and C. Bjartmar. 1993. Myelinated nerve
fibres in the CNS. Prog. Neurobiol. 40:319–384.
Ishii, T., E. Satoh, and M. Nishimura. 2001. Integrin-linked kinase controls
neurite outgrowth in N1E-115 neuroblastoma cells. J. Biol. Chem. 276:
42994–43003.
Kitamura, T., W. Ogawa, H. Sakaue, Y. Hino, S. Kuroda, M. Takata, M. Matsu-
moto, T. Maeda, H. Konishi, U. Kikkawa, and M. Kasuga. 1998. Require-
ment for activation of the serine-threonine kinase Akt (protein kinase B) in
insulin stimulation of protein synthesis but not of glucose transport. Mol.
Cell. Biol. 18:3708–3717.
Li, F., Y. Zhang, and C. Wu. 1999. Integrin-linked kinase is localized to cell-
matrix focal adhesions but not cell-cell adhesion sites and the focal adhesion
localization of integrin-linked kinase is regulated by the PINCH-binding
ANK repeats. J. Cell Sci. 112:4589–4599.
Mackinnon, A.C., H. Qadota, K.R. Norman, D.G. Moerman, and B.D. Williams.
2002. C. elegans PAT-4/ILK functions as an adaptor protein within integrin
adhesion complexes. Curr. Biol. 12:787–797.
Matsumura, K., H. Yamada, F. Saito, Y. Sunada, and T. Shimizu. 1997. Peripheral
nerve involvement in merosin-deficient congenital muscular dystrophy and
dy mouse. Neuromuscul. Disord. 7:7–12.
Morandi, L., C. Di Blasi, L. Farina, L. Sorokin, G. Uziel, G. Azan, A. Pini, A.
Toscano, M. Lanfossi, S. Galbiati, et al. 1999. Clinical correlations in 16 pa-
tients with total or partial laminin alpha2 deficiency characterized using an-
tibodies against 2 fragments of the protein. Arch. Neurol. 56:209–215.
Nikolopoulos, S.N., and C.E. Turner. 2001. Integrin-linked kinase (ILK) binding
to paxillin LD1 motif regulates ILK localization to focal adhesions. J. Biol.
Chem. 276:23499–23505.
Park, S.K., R. Miller, I. Krane, and T. Vartanian. 2001. The erbB2 gene is required
for the development of terminally differentiated spinal cord oligodendro-
cytes. J. Cell Biol. 154:1245–1258.
Persad, S., S. Attwell, V. Gray, M. Delcommenne, A. Troussard, J. Sanghera, and S.
Dedhar. 2000. Inhibition of integrin-linked kinase (ILK) suppresses activation
of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-
mutant prostate cancer cells. Proc. Natl. Acad. Sci. USA. 97:3207–3212.
Powell, S.K., C.C. Williams, M. Nomizu, Y. Yamada, and H.K. Kleinman. 1998.
Laminin-like proteins are differentially regulated during cerebellar develop-
ment and stimulate granule cell neurite outgrowth in vitro. J. Neurosci. Res.
54:233–247.
Rasband, M.N., E. Peles, J.S. Trimmer, S.R. Levinson, S.E. Lux, and P. Shrager.
1999. Dependence of nodal sodium channel clustering on paranodal axoglial
contact in the developing CNS. J. Neurosci. 19:7516–7528.
Sakai, T., S. Li, D. Docheva, C. Grashoff, K. Sakai, G. Kostka, A. Braun, A. Pfei-
fer, P.D. Yurchenco, and R. Fassler. 2003. Integrin-linked kinase (ILK) is re-
quired for polarizing the epiblast, cell adhesion, and controlling actin accu-
mulation. Genes Dev. 17:926–940.
Schwab, M.E., and L. Schnell. 1989. Region-specific appearance of myelin constit-
uents in the developing rat spinal cord. J. Neurocytol. 18:161–169.
Scott-Drew, S., and C. ffrench-Constant. 1997. Expression and function of throm-
bospondin-1 in myelinating glial cells of the central nervous system. J. Neu-
rosci. Res. 50:202–214.
Seger, D., R. Seger, and S. Shaltiel. 2001. The CK2 phosphorylation of vitronec-
tin. Promotion of cell adhesion via the alpha(v)beta 3-phosphatidylinositol
3-kinase pathway. J. Biol. Chem. 276:16998–17006.
Sperber, B.R., E.A. Boyle-Walsh, M.J. Engleka, P. Gadue, A.C. Peterson, P.L.
Stein, S.S. Scherer, and F.A. McMorris. 2001. A unique role for Fyn in CNS
myelination. 2001. J. Neurosci. 21:2039–2047.
Taylor, A.R., S.E. Geden, and C. Fernandez-Valle. 2003. Formation of a beta1 in-
tegrin signaling complex in Schwann cells is independent of rho. Glia. 41:
94–104.
Troussard, A.A., N.M. Mawji, C. Ong, A. Mui, R. St-Arnaud, and S. Dedhar. 2003.
Conditional knock-out of integrin-linked kinase demonstrates an essential
role in protein kinase B/Akt activation. J. Biol. Chem. 278:22374–22378.
Tsuji, S., and H. Matsushita. 1985. Evidence on hypomyelination of central ner-
vous system in murine muscular dystrophy. J. Neurol. Sci. 68:175–184.
Tu, Y., Y. Huang, Y. Zhang, Y. Hua, and C. Wu. 2001. A new focal adhesion pro-
tein that interacts with integrin-linked kinase and regulates cell adhesion and
spreading. J. Cell Biol. 153:585–598.
Turner, C.E. 2000. Paxillin and focal adhesion signalling. Nat. Cell Biol. 2:E231–
E236.
Umemori, H., S. Sato, T. Yagi, S. Aizawa, and T. Yamamoto. 1994. Initial events
of myelination involve Fyn tyrosine kinase signalling. Nature. 367:572–576.
Vartanian, T., A. Goodearl, A. Viehover, and G. Fischbach. 1997. Axonal neureg-
ulin signals cells of the oligodendrocyte lineage through activation of HER4
and Schwann cells through HER2 and HER3. J. Cell Biol. 137:211–220.
Wu, C., and S. Dedhar. 2001. Integrin-linked kinase (ILK) and its interactors: a
new paradigm for the coupling of extracellular matrix to actin cytoskeleton
and signaling complexes. J. Cell Biol. 155:505–510.
Zervas, C.G., S.L. Gregory, and N.H. Brown. 2001. Drosophila integrin-linked ki-
nase is required at sites of integrin adhesion to link the cytoskeleton to the
plasma membrane. J. Cell Biol. 152:1007–1018.